Journey Medical DERM
NASDAQ DERM
$6.61 -0.11 (-1.64%)
At close: Oct 2, 2026 · 4:00 PM EDT

Journey Medical (DERM) Selling, General & Administrative (2020 - 2026)

Updated

Journey Medical's Selling, General & Administrative was $10.89 million in Q2 2026, down 8.4% from $11.88 million a year earlier but up 7.7% from the prior quarter.

Analysis

Journey Medical (DERM) Selling, General & Administrative (2020 - 2026) Analysis & Trends

On a trailing twelve-month basis, Journey Medical's Selling, General & Administrative was $42.91 million through Jun 30, 2026, down 2.3% year-over-year; for FY2025, it was $44.37 million, up 10.4% from FY2024.

  • Selling, General & Administrative shows a five-year compound annual growth rate of 15.0% (FY2020 to FY2025).
  • In earlier years, Selling, General & Administrative was $40.2 million in FY2024 (-8.4%), $43.91 million in FY2023 (-26.2%), $59.47 million in FY2022 (+49.3%) and $39.83 million in FY2021 (+80.4%).
  • Quarterly Selling, General & Administrative has moved between $8.42 million (Q1 2024) and $15.58 million (Q3 2022) over five years.
  • Compared with a year earlier, Selling, General & Administrative has declined for three straight quarters, with growth averaging 8.2% over the last eight quarters.
  • The best year-over-year quarter for Selling, General & Administrative over five years was Q4 2021 (growth of 158.9%); the worst was Q3 2023 (a decline of 44.6%).
  • Per Business Quant data, DERM's Selling, General & Administrative in the three quarters before Q2 2026 was $10.11 million (Q1 2026), $9.86 million (Q4 2025) and $12.05 million (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) SG&A (Qtr)
1 Eli Lilly 1,082.65 Bn 1,051.23 Bn 19.71 Bn 3.43 Bn
2 Johnson & Johnson 623.68 Bn 542.21 Bn 17.26 Bn 6.43 Bn
3 AbbVie 459.43 Bn 432.59 Bn 12.70 Bn 3.63 Bn
4 Merck 354.80 Bn 309.23 Bn 12.21 Bn 2.90 Bn
5 Novartis Ag 269.16 Bn 225.03 Bn 11.24 Bn -3.24 Bn
6 Astrazeneca 244.40 Bn 217.97 Bn 12.86 Bn -5.65 Bn
7 Amgen 220.17 Bn 175.57 Bn 7.24 Bn 1.75 Bn
8 Gilead Sciences 183.05 Bn 157.16 Bn 6.22 Bn 1.92 Bn
9 Pfizer 160.27 Bn 107.22 Bn 10.94 Bn 3.41 Bn
10 Journey Medical 184.76 Mn 82.85 Mn 12.37 Mn 10.89 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 10.89 Mn
Mar 31, 2026 10.11 Mn
Dec 31, 2025 9.86 Mn
Sep 30, 2025 12.05 Mn
Jun 30, 2025 11.88 Mn
Mar 31, 2025 10.57 Mn
Dec 31, 2024 10.06 Mn
Sep 30, 2024 11.40 Mn
Jun 30, 2024 10.33 Mn
Mar 31, 2024 8.42 Mn
Dec 31, 2023 9.84 Mn
Sep 30, 2023 8.64 Mn
Jun 30, 2023 12.14 Mn
Mar 31, 2023 13.29 Mn
Dec 31, 2022 13.99 Mn
Sep 30, 2022 15.58 Mn
Jun 30, 2022 15.19 Mn
Mar 31, 2022 14.72 Mn
Dec 31, 2021 15.06 Mn
Sep 30, 2021 10.76 Mn
API Access

Journey Medical Selling, General & Administrative API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=selling-general-and-administrative&ticker=DERM&period=max&api_key=YOUR_API_KEY